IBM Watson

By Jonah Comstock May 3, 2017
IBM Watson hosts AI X Prize. With the Tricorder X Prize concluded, the X Prize foundation is tackling another hot topic in healthcare: artificial intelligence. Although the IBM Watson-sponsored $5 million prize allows participants to tackle any problem they want, expect to see a number of entries in healthcare, where AI is currently a hot topic and where IBM Watson has been invested for some time...
By Heather Mack March 15, 2017
Telehealth provider InTouch Health and Dignity Health have expanded their partnership, extending InTouch’s existing services in Dignity’s acute care settings into post-acute and ambulatory facilities. With new software, tablet and care options, InTouch Health’s services can go to any patient location with a laptop, tablet or fully-integrated solution that is designed for specific conditions,...
By Heather Mack March 14, 2017
Millions of people around the world are living with arthritis. In the United States alone, the Centers for Disease Control puts that figure at nearly 23 million, or one in every four adults. But as common as it is, arthritis is actually just one word used to describe the joint inflammation associated with over 200 musculoskeletal conditions that affect everyone differently. This means people who...
By Bernie Monegain February 1, 2017
Jupiter Medical Center, a not-for-profit 327-bed regional medical center in Jupiter, Florida, will employ cognitive computing platform IBM Watson for Oncology. Jupiter is the first US community hospital to adopt the technology. The goal: to provide insights to physicians to help them deliver personalized, evidence-based cancer treatment. In the U.S., there will be an estimated 1.7 million new...
By Heather Mack January 16, 2017
Health enterprise SaaS company Welltok announced an expanded partnership with IBM Watson Health. Health managers using Welltok’s CafeWell Health Optimization Platform to organize individual’s health resources and benefits will have the data analytics and cognitive computing technology of IBM Watson to improve their approach to consumer health, including episodic clinical care and everyday...
By Heather Mack October 26, 2016
Global pharmaceutical company Teva has joined forces with IBM in a three-year research collaboration that integrates with the Watson Health Cloud. The project builds on an existing alliance between the two companies and will focus on two key areas in healthcare: developing a systematic approach to discovering new uses for existing drugs and improving chronic disease management. The joint work in...
By Heather Mack September 16, 2016
Austria and San Diego-based MySugr, a diabetes management coaching app announced a partnership with Abbott in the UK. Abbott has a wearable interstitial glucose monitor called the FreeStyle Libre Flash Glucose Monitoring System. The system, which is not yet available in the US, consists of a patch that continually reads blood glucose and an NFC reader device that the user can hold over the patch...
By MobiHealthNews August 12, 2016
Over the years, more and more companies have gone public in the digital health space and existing public companies have gotten into the space, either on their own or thorugh acquisitions. Here's a roundup of digital health talk on the latest round of second quarter investor calls and quarterly finance reports. Fitbit. San Francisco-based Fitbit, maker of a series of popular wearable activity...
By Jonah Comstock June 23, 2016
As the $10 million Qualcomm Tricorder X Prize draws to a close, the X Prize Foundation has teamed up with IBM Watson to launch a new contest, a $5 million open challenge to develop an AI application that could be focused in the area of healthcare -- but could also be aimed at education, energy, environment, global development or exploration. “In the coming decade, as X Prize strives to achieve...
By Aditi Pai April 7, 2016
Pfizer has partnered with IBM to develop a system that clinicians can use to treat patients who have Parkinson’s disease. The system will make use of sensors, mobile devices, and machine learning to provide clinicians and researchers with symptom information, which they will then use to better understand patient disease progression and medication response. It will also help inform treatment...

Editor's Pick